These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25683360)

  • 1. Cancer of unknown primary: does the key lie in molecular diagnostics?
    Green AC
    Cytopathology; 2015 Feb; 26(1):61-3. PubMed ID: 25683360
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis, pathology, treatment, and nursing considerations for cancer of unknown primary.
    Winkeljohn DL
    Clin J Oncol Nurs; 2009 Jun; 13(3):273-5. PubMed ID: 19502184
    [No Abstract]   [Full Text] [Related]  

  • 3. Unknown primary tumors.
    Raber MN; Abbruzzese JL; Frost P
    Curr Opin Oncol; 1992 Feb; 4(1):3-9. PubMed ID: 1591292
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis and therapy of tumors from an unknown primary site].
    Novik AV; Moiseenko VM
    Vopr Onkol; 2004; 50(3):271-8. PubMed ID: 15318700
    [No Abstract]   [Full Text] [Related]  

  • 5. Worst case scenario: carcinoma of unknown origin.
    Cibull ML
    Diagn Cytopathol; 2006 May; 34(5):311-2. PubMed ID: 16604548
    [No Abstract]   [Full Text] [Related]  

  • 6. SEOM clinical guideline on unknown primary cancer (2017).
    Losa F; Soler G; Casado A; Estival A; Fernández I; Giménez S; Longo F; Pazo-Cid R; Salgado J; Seguí MÁ
    Clin Transl Oncol; 2018 Jan; 20(1):89-96. PubMed ID: 29230692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer from an unknown primary site.
    Dowell JE
    Am J Med Sci; 2003 Jul; 326(1):35-46. PubMed ID: 12861124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of unknown primary tumor.
    Chepeha D; Koch W; Pitman K
    Head Neck; 2003 Jun; 25(6):499-504. PubMed ID: 12784242
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fizazi K; Greco FA; Pavlidis N; Daugaard G; Oien K; Pentheroudakis G;
    Ann Oncol; 2015 Sep; 26 Suppl 5():v133-8. PubMed ID: 26314775
    [No Abstract]   [Full Text] [Related]  

  • 10. [Unknown primary neoplasms with isolated metastases to cervical lymph nodes: current questions].
    Mikhnin AE; Frolova OS
    Vopr Onkol; 2013; 59(2):27-33. PubMed ID: 23814846
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.
    Briasoulis E; Pavlidis N; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii106-7. PubMed ID: 18456742
    [No Abstract]   [Full Text] [Related]  

  • 12. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
    Pavel M; Baudin E; Couvelard A; Krenning E; Öberg K; Steinmüller T; Anlauf M; Wiedenmann B; Salazar R;
    Neuroendocrinology; 2012; 95(2):157-76. PubMed ID: 22262022
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fizazi K; Greco FA; Pavlidis N; Pentheroudakis G;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi64-8. PubMed ID: 21908507
    [No Abstract]   [Full Text] [Related]  

  • 14. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
    Briasoulis E; Tolis C; Bergh J; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i75-6. PubMed ID: 15888766
    [No Abstract]   [Full Text] [Related]  

  • 15. [Unknown primary tumour--diagnostic strategies and treatment].
    Møller AK; Gundgaard MG; Petersen BL; Daugaard G
    Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging enhances diagnostic and management targets in patients with cancer of unknown primary site.
    Guimarães MD; Chojniak R; Marchiori E
    AJR Am J Roentgenol; 2013 Dec; 201(6):W919. PubMed ID: 24261403
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic and therapeutic approach in cancer of metastatic presentation and unknown origin].
    Losa Gaspà F; Germà Lluch JR; Camacho Cuartero L; Niubó Daniel R; Albareda Boleda JM; Sanuy Jiménez B; Martos Rodríguez A
    Rev Clin Esp; 2002 Nov; 202(11):604-14. PubMed ID: 12392650
    [No Abstract]   [Full Text] [Related]  

  • 18. Occult primary cancer clinical practice guidelines.
    Ettinger DS; Arnoletti JP; Gockerman JP; Handorf C; Havlin KA; Jacobs CD; Javle M; Kvols L; Lenzi R; Rashid A; Rhoades CA; Ridge JA; Saltz L; Shulman LN; Sondak VK; Thompson JA; Twardowski P; Zhen W;
    J Natl Compr Canc Netw; 2005 Mar; 3(2):214-33. PubMed ID: 19817031
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer of unknown primary site.
    Varadhachary GR; Raber MN
    N Engl J Med; 2014 Aug; 371(8):757-65. PubMed ID: 25140961
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic and therapeutic management of carcinoma of unknown primary: histopathological and molecular diagnosis.
    Viale G; Mastropasqua MG
    Ann Oncol; 2006 Sep; 17 Suppl 10():x163-7. PubMed ID: 17018717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.